CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care
22. Januar 2024 09:00 ET
|
Truveta
BELLEVUE, Wash., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Today, Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S....
BIMI International Medical Inc. Announces First Quarter 2023 Financial Results
22. Mai 2023 09:25 ET
|
BIMI International Medical Inc.
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended...
Talis Biomedical Corporation (TLIS) Investor News: Robbins LLP Reminds Investors it is Investigating TLIS on Behalf of Shareholders
09. Mai 2023 12:43 ET
|
Robbins LLP
SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Talis Biomedical Corporation (NASDAQ: TLIS) to determine whether certain Talis officers and...
Invivyd, Inc. (IVVD) Investor Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline in Invivyd, Inc. Class Action
24. März 2023 13:44 ET
|
Robbins LLP
SAN DIEGO, March 24, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
23. Februar 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
23. Februar 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
Invivyd, Inc. (IVVD) Class Action Alert: Robbins LLP Urges Shareholders to Contact the Firm Regarding Representation in the Class Action Against Invivyd, Inc.
16. Februar 2023 15:03 ET
|
Robbins LLP
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...
Invivyd, Inc. (IVVD) f/k/a Adagio Therapeutics, Inc. Shareholder Notice: Robbins LLP Informs Investors of Class Action Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc.
07. Februar 2023 13:05 ET
|
Robbins LLP
SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Invivyd, Inc. (NASDAQ: IVVD) f/k/a...
Truveta’s COVID-19 health equity research published in Frontiers in Public Health
19. Januar 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 health equity research published in Frontiers in Public Health using de-identified patient data from Truveta...
Veru Inc. (VERU) Equity Alert: Contact Robbins LLP for Information About the Class Action Against Veru Inc.
14. Dezember 2022 17:24 ET
|
Robbins LLP
SAN DIEGO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Veru...